by Dr. Beth Muckley, Ohio Optometric Association Trustee

Under the Physician Payments Sunshine Act, financial relationships that drug and device makers have with doctors must be disclosed.

The Rule, “finalizes the provisions that require manufacturers of drugs, devices, biologicals, and medical supplies covered by Medicare, Medicaid, or the Children’s Health Insurance Program to report payments or other transfers of value they make to physicians and teaching hospitals to CMS,” the statement explained. “CMS will post that data to a public website. The final rule also requires manufacturers and group purchasing organizations (GPOs) to disclose to CMS physician ownership or investment interests.”

More information: http://bit.ly/14AbJXu